MedPath

Balloon Guide Catheter to Optimize Outcomes in Stroke Thrombectomy of the Internal Carotid Artery

Not Applicable
Not yet recruiting
Conditions
Stroke
Registration Number
NCT07192029
Lead Sponsor
Xuanwu Hospital, Beijing
Brief Summary

To investigate whether using balloon guide catheter with flow arrest during mechanical thrombectomy, compared to non-flow arrest, improves the rate of first pass expanded Thrombolysis in Cerebral Infarction score (eTICI 2c-3) reperfusion for acute ischemic stroke due to internal carotid artery occlusion

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
364
Inclusion Criteria
  1. age ≥18 years;
  2. Clinical diagnosis of acute ischemic stroke with internal carotid artery occlusion confirmed by imaging (CTA/MRA/DSA), including isolated intracranial internal carotid artery (I-type), internal carotid artery intracranial segment involving middle cerebral artery (L-type), or internal carotid artery intracranial segment involving middle and anterior cerebral arteries (T-type) (including tandem embolic occlusions of the internal carotid artery C1 or common carotid artery);
  3. Baseline NIHSS≥6, and meeting local guidelines for mechanical thrombectomy;
  4. Time from onset or last known normal to randomization within 24 hours and proceeding to mechanical thrombectomy;
  5. Signed informed consent (or by legal representative).
Exclusion Criteria
  1. Pre-stroke mRS score of 0-2
  2. Intracranial hemorrhage shown on imaging;
  3. Known or suspected internal carotid artery occlusion caused by dissection or atherosclerosis;
  4. Vascular tortuosity preventing the use of balloon guide catheter;
  5. Prior stent implantation in the target vessel that would impede the use or removal of mechanical thrombectomy devices;
  6. Any other circumstances impeding mechanical thrombectomy implementation;
  7. Acute occlusion of multiple vascular territories in bilateral anterior circulation or in both the anterior and posterior circulations confirmed by CTA/MRA;
  8. Pregnant subjects;
  9. Subjects allergic to contrast agents;
  10. Subjects refusing to cooperate or unable to tolerate interventional procedures;
  11. Subjects whose expected lifetime are less than 90 days;
  12. Midline shift or herniation with ventricular mass effect;
  13. Subjects deemed unable to participate in follow-up by investigators;
  14. Other situations deemed unsuitable for balloon guide catheter use by investigators.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Rate of first-pass reperfusion defined as eTICI 2c-3 reperfusionPerioperative
Secondary Outcome Measures
NameTimeMethod
Ordinal Distribution of mRS Scores (mRS Shift analysis)90 days (±7 days)
Change in stroke severity (NIHSS score)7 days or discharge (whichever occurs first);
Technical success ratePerioperative

Defined as the successful delivery of the guiding catheter to the target vessel and completion of the thrombectomy process without replacing the guiding catheter

Number of mechanical thrombectomy attemptsPerioperative
Final angiographic reperfusion results (eTICI ≥2b, eTICI ≥2c, eTICI 3)Perioperative
Good outcome proportion, defined as mRS score 0-290 days (±7 days) post-procedure
Reperfusion results (eTICI ≥2b, eTICI 3)Perioperative
Time from groin puncture to successful reperfusion (eTICI ≥2b, eTICI ≥2c);Perioperative
EQ-5D-5L score90 ± 7 days after surgery
Proportion of participants with a Barthel Index score of ≥9590 ± 7 days after surgery

Trial Locations

Locations (1)

Xuanwu Hospital, Capital Medical University.

🇨🇳

Beijing, China

Xuanwu Hospital, Capital Medical University.
🇨🇳Beijing, China

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.